Business Context and Reporting Period
Company: Lifecore Biomedical, Inc. (LFCR)
Filing Type: Form 8-K (Current Report)
Date of Report: October 12, 2023 (Event Date)
Reporting Period: The filing addresses delinquencies regarding the fiscal quarter ended August 27, 2023, and the fiscal year ended May 28, 2023.
Key Financial Metrics
This Form 8-K is a disclosure of regulatory status and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The report specifically notes the failure to file the required Form 10-Q and Form 10-K containing such data.
Material Changes and Regulatory Status
- Nasdaq Non-Compliance: The Company received a notification from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to delays in filing its Form 10-Q (ended August 27, 2023) and Form 10-K (ended May 28, 2023).
- Trading Status: The notification has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Global Select Market.
- Compliance Plan: The Company submitted a plan to regain compliance on October 16, 2023. If accepted, Nasdaq may grant up to 180 calendar days from the original due date (February 12, 2024) to file the delinquent reports.
Outlook, Risks, and Management Commentary
Management Commentary: The Company states it is working diligently to complete the delinquent filings and plans to file them as promptly as possible to regain compliance.
Risks and Contingencies:
- Uncertainty regarding the ability to respond timely to Nasdaq inquiries.
- Risk of failing to regain compliance with Nasdaq Listing Rules.
- Risk that the completion and filing of the delinquent reports will take longer than expected.
Forward-Looking Statements: The filing includes standard cautionary language noting that actual results may differ materially from expectations due to the aforementioned risks.
Investor Verification Checklist
- Verify the current status of the Company's compliance plan with Nasdaq.
- Monitor for the eventual filing of the delinquent Form 10-Q (ended August 27, 2023) and Form 10-K (ended May 28, 2023) to obtain actual financial metrics.
- Check for any subsequent communications from Nasdaq regarding the acceptance or rejection of the compliance plan.
- Review the Company's most recent filed Annual Report on Form 10-K/A for historical risk factors.